GSE235701 GSE261434 enasidenib 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE235701_GSE261434_enasidenib_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE235701_GSE261434_enasidenib_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE235701_GSE261434_enasidenib_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE235701_GSE261434_enasidenib_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

S100 calcium binding protein P

Gene

clusterin

Gene

secreted frizzled related protein 1

Gene

activating transcription factor 3

Gene

inhibitor of DNA binding 1

Gene

aldo-keto reductase family 1 member C2

Gene

MAGE family member A6

Gene

adhesion molecule with Ig like domain 2

Gene

aldo-keto reductase family 1 member B10

Gene

3-hydroxy-3-methylglutaryl-CoA synthase 1

  • Gene

    S100 calcium binding protein P



  • Gene

    secreted frizzled related protein 1


  • Gene

    activating transcription factor 3


  • Gene

    inhibitor of DNA binding 1


  • Gene

    aldo-keto reductase family 1 member C2


  • Gene

    MAGE family member A6


  • Gene

    adhesion molecule with Ig like domain 2


  • Gene

    aldo-keto reductase family 1 member B10


  • Gene

    3-hydroxy-3-methylglutaryl-CoA synthase 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.